Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial

Critical Care Medicine

Volumn 26, Issue 1, 1998, Pages 15-23

  Dellinger, R Phillip ^a   Zimmerman, Janice L ^b   Taylor, Robert W ^c   Sträube, Richard C ^d   Hauser, David L ^d   Criner, Gerard J ^e   Davis Jr , Kenneth ^f   Hyers, Thomas M ^g   Papadakos, Peter ^h  

^a UNIVERSITY OF MISSOURI   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c ST JOHN S MERCY MEDICAL CENTER   (United States)

^d Ohmeda Pharmaceutical Products Division   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g SAINT LOUIS UNIVERSITY   (United States)

^h UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Aspiration; Intensive care; Mechanical ventilation; Nitric oxide; Pneumonia; Respiratory failure

Indexed keywords

NITRIC OXIDE; PLACEBO;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COMMUNITY HOSPITAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OXYGENATION; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TEACHING HOSPITAL; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL; VENTILATOR;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RESPIRATION; RESPIRATORY DISTRESS SYNDROME, ADULT; SAFETY; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031975630     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199801000-00011     Document Type: Article

References (24)

1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142
2. Ignarro LJ, Buga GM, Wood KS, et al: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987; 84:9265-9269
3. Furchgott RF, Vanhoutte PM: Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3:2007-2018
4. Gibson QH, Roughton FJW: The kinetics of equilibria of the reactions of nitric oxide with sheep hemoglobin. J Physiol (London) 1957; 136:507-526
5. Fratacci MD, Frostell CG, Chen TY, et al: Inhaled nitric oxide: A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991; 75:990-999
6. Dyar O, Young JD.XiongL, etal: Dose-response relationship for inhaled nitric oxide in experimental pulmonary hypertension in sheep. Br J Anaesthesia 1993; 71:702-708
7. Katayama Y, Hatanaka K, Hayashi T, et al: Effects of inhaled nitric oxide in rats with chemically induced pulmonary hypertension. Respir Physiol 1994; 97:301-307
8. Jacob TD, Nakayama DK, Seki I, et al: Hemodynamic effects and metabolic fate of inhaled nitric oxide in hypoxic piglets. J Appl Physiol 1994; 76:1794-1801
9. Rossaint R, Falke KJ, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl J Med 1993; 328:399-405
10. Frostell CG, Blomqvist H, Hedenstierna G, et al: Inhaled nitric oxide selectivity reverses human hypoxic vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 78:427-435
11. Gerlach H, Rossaint R, Pappert D, et al: Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23:499-502
12. Roberts JD, Polaner DM, Lang P, et al: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:818-819
13. Kinsella JP, Neish SR, Shaffer E, et al: Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:819-820
14. The Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336:596-604
15. Roberts JD, Fineman JR, Morin FC, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the new born. N Engl J Med 1997;336:605-610
16. Roberts JD, Lang P, Bigatello LM, et al: Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87:447-453
17. Rich GF, Murphy GD, Roos CM, et al: Inhaled nitric oxide: Selective pulmo-nary vasodilation in cardiac surgical patients. Anesthesiology 1993; 78:10281035
18. Girard C, Lehot JJ, Pannetar JC, et al: Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77:880-883
19. Pepke-Zaba J, Higenbottam T, Tinh-Xvan AT, et al: Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991; 338:1173-1174
20. Radomski MW, Moncada S: The biological and pharmacological role of nitric oxide in platelet function. Adv Exp Med Biol 1993; 344:251-264
21. Samama CM, Diaby M, Fellahi J-L, et al: Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1995; 83:56-65
22. Wink DA, Hanbauer I, Laval F, et al: Nitric oxide protects against cytotoxic effects of reactive oxygen species. Ann NY Acad Sci 1994; 738:265-278
23. Chollet-Martin S, Gatecel C, Kermarrec N, et al: Alveolar neutrophil functions and cytokine levels in patients with the acute respiratory distress syndrome during nitric oxide inhalation. Am J Respir Crit Care Med 1996; 153:985-990
24. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-824